A novel five-lncRNA signature panel improves high-risk survival prediction in patients with cholangiocarcinoma

Author:

Xie Xiaozai12,Wang Yi3,Zhang Sina34,Li Jialiang12,Yu Zhengping1,Ding Xiwei5,Ye Longyun1,Gong Peirong6,Zhu Qiandong1,Li Junjian1,Chen Ziyan7,Yao Xinfei7,Du Zhiyong8,Zeng Qiqiang12,Chen Hanbin9,Yang Zhen10,Chen Gang12

Affiliation:

1. Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

2. Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

3. Department of Epidemiology and Biostatistics, School of Public Health and Management, Wenzhou Medical University, Wenzhou, China

4. School of Public Health, Inner Mongolia Medical University, Hohhot, China

5. Department of Gastroenterology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China

6. Department of Hepatobiliary Surgery, The Affiliated Cixi Hospital of Wenzhou Medical University, Ningbo, China

7. Division of Clinical Medicine, First School of Clinical Medicine, Wenzhou Medical University, Wenzhou, China

8. Department of Hepatobiliary Surgery, Shenzhen People’s Hospital, Shenzhen, China

9. Department of Radiotherapy and Chemotherapy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

10. Department of Infectious Diseases, Shandong Provincial Hospital, Jinan, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3